Literature DB >> 29063874

A rare case of pancreatic metastasis of angiosarcoma: Diagnosed by endoscopic ultrasound-guided fine-needle aspiration and biopsy.

Manoop S Bhutani1, Ayush Arora1, Uma Kundu2, Dipen Maru2.   

Abstract

Entities:  

Year:  2017        PMID: 29063874      PMCID: PMC5664856          DOI: 10.4103/2303-9027.216719

Source DB:  PubMed          Journal:  Endosc Ultrasound        ISSN: 2226-7190            Impact factor:   5.628


× No keyword cloud information.
A 55-year-old female, with primary splenic angiosarcoma with metastatic lesions in liver, T-8 vertebra and left femur, status postsplenectomy, right hepatectomy and cholecystectomy, and multiple cycles of chemotherapy, was found to have a new 0.5 cm ill-defined attenuation focus in the body of pancreas on routine surveillance computed tomography (CT) scan. Follow-up of CT 2 months later revealed increase in size of the same mass to 0.8 cm [Figure 1], worrisome of progressive metastatic lesion from angiosarcoma. The patient was referred for endoscopic ultrasound (EUS)-guided fine-needle aspiration and biopsy (FNAB). On EUS [Figure 2], an 8 mm × 6 mm isoechoic rounded mass was seen in the pancreatic body. Transgastric EUS-guided fine-needle aspiration (two passes) and fine-needle core biopsy (two passes) were done using a 25 G, ProCore EUS needle (Cook). On cytology, specimens along with immunostains performed on the cell block sections showed that the neoplastic cells were positive for ERG and CD31 and focally/weakly positive for pan-cytokeratin. Immunohistochemical staining of the core biopsy revealed that the tumor cells were strongly positive for ERG (nuclear pattern), focally positive for CD31 and CD34, and negative for synaptophysin and chromogranin. This was consistent with metastatic angiosarcoma [Figures 3–6].
Figure 1

Computed tomography scan showing (arrow) a small, 8 mm, subtle, ill-defined mass in the pancreatic body

Figure 2

Endoscopic ultrasound exam revealing the same lesion (arrows) that was subjected to endoscopic ultrasound-guided fine-needle aspiration and core biopsy

Figure 3

Papanicolaou-stained smear shows a group of spindled to epithelioid cells with coarse chromatin pattern consistent with the patient's history of angiosarcoma

Figure 6

Immunohistochemistry performed on the cell block preparation shows positive staining for ERG, consistent with angiosarcoma

Computed tomography scan showing (arrow) a small, 8 mm, subtle, ill-defined mass in the pancreatic body Endoscopic ultrasound exam revealing the same lesion (arrows) that was subjected to endoscopic ultrasound-guided fine-needle aspiration and core biopsy Papanicolaou-stained smear shows a group of spindled to epithelioid cells with coarse chromatin pattern consistent with the patient's history of angiosarcoma H and E stain of a cell block preparation demonstrates a small of groups of neoplastic spindle cells Immunohistochemistry performed on the cell block preparation shows positive staining for CD31, consistent with angiosarcoma Immunohistochemistry performed on the cell block preparation shows positive staining for ERG, consistent with angiosarcoma Angiosarcomas are rare, malignant, and frequently fatal soft tissue tumors and may metastasize to almost all visceral organs including pancreas. Definitive diagnosis can be made only with immunochemistry, and hence, obtaining biopsy is of paramount importance. EUS-FNAB has previously been described for diagnosing angiosarcoma in suprarenal gland[1] and spleen[2] in two prior case reports. To our knowledge, we present the first case of EUS-FNAB use for diagnosis of angiosarcoma within the pancreas. Primary angiosarcoma in pancreas may present as acute pancreatitis and diagnosis may be missed if biopsy is not performed as described by Csiszkó et al.[3] and Seth et al.[4] separately in their case reports. We recommend keeping angiosarcoma as a possible rare differential while evaluating pancreatic masses and using EUS-guided FNAB with these well-evaluated core needles[56] to confirm the diagnosis.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given her consent for her images and other clinical information to be reported in the journal. The patients understand that her name and initial will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Angiosarcoma of the pancreas: discussion of a rare epithelioid neoplasm.

Authors:  Akhil K Seth; Pedram Argani; Kurtis A Campbell
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

2.  Primary angiosarcoma of the pancreas mimicking severe acute pancreatitis--case report.

Authors:  Adrienn Csiszkó; István László; Károly Palatka; Károly Gábor Szabó; Zsolt Kanyári; László Bidiga; Tamás Csonka; László Damjanovich; Zsolt Szentkereszty
Journal:  Pancreatology       Date:  2014-12-06       Impact factor: 3.996

Review 3.  Cytological diagnosis of angiosarcoma arising in an immunosuppressed patient 6 years after multi-visceral transplantation: a case report and literature review.

Authors:  Xiaowei Chen; Stephen M Lagana; John Poneros; Tomoaki Kato; Fabrizio Remotti; Huangjun He; Dmitry Kaminsky; Diane Hamele-Bena
Journal:  Diagn Cytopathol       Date:  2013-11-07       Impact factor: 1.582

4.  Comparison of endoscopic ultrasound guided 22-gauge core needle with standard 25-gauge fine-needle aspiration for diagnosing solid pancreatic lesions.

Authors:  Manuel Berzosa; Nicolas Villa; Hasheme B El-Serag; Divyesh V Sejpal; Kalpesh K Patel
Journal:  Endosc Ultrasound       Date:  2015 Jan-Mar       Impact factor: 5.628

5.  Pathologic evaluation of a new endoscopic ultrasound needle designed to obtain core tissue samples: A pilot study.

Authors:  Douglas G Adler; Benjamin Witt; Barbara Chadwick; Jason Wells; Linda Jo Taylor; Christopher Dimaio; Robert Schmidt
Journal:  Endosc Ultrasound       Date:  2016 May-Jun       Impact factor: 5.628

6.  Angiosarcoma involving solid organs and the gastrointestinal tract with life-threatening bleeding.

Authors:  Chiaki Maeyashiki; Naoyoshi Nagata; Naomi Uemura
Journal:  Case Rep Gastroenterol       Date:  2012-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.